Tenet Healthcare (NYSE:THC) Director Sells $293,000.00 in Stock

Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Roy Blunt sold 1,000 shares of the firm’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $293.00, for a total value of $293,000.00. Following the completion of the transaction, the director owned 3,589 shares of the company’s stock, valued at approximately $1,051,577. This represents a 21.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Tenet Healthcare Trading Up 0.1%

NYSE:THC opened at $286.34 on Monday. The company has a market capitalization of $22.79 billion, a PE ratio of 8.30, a price-to-earnings-growth ratio of 1.53 and a beta of 1.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $301.44. The stock has a fifty day simple moving average of $267.83 and a 200-day simple moving average of $224.88.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm had revenue of $6.28 billion for the quarter, compared to analysts’ expectations of $5.49 billion. During the same period in the prior year, the company earned $3.70 EPS. The firm’s revenue was up 6.5% on a year-over-year basis. On average, equities research analysts expect that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Stephens reiterated an “overweight” rating and issued a $285.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 17th. TD Cowen lifted their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Weiss Ratings raised Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Finally, Royal Bank Of Canada increased their target price on Tenet Healthcare from $283.00 to $304.00 and gave the company an “outperform” rating in a report on Monday, November 2nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average target price of $296.65.

Read Our Latest Research Report on Tenet Healthcare

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of THC. V Square Quantitative Management LLC purchased a new position in shares of Tenet Healthcare during the 3rd quarter worth about $26,000. Mather Group LLC. grew its holdings in Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after purchasing an additional 66 shares during the period. MADDEN SECURITIES Corp purchased a new stake in Tenet Healthcare in the third quarter valued at approximately $38,000. Trust Co. of Vermont acquired a new position in Tenet Healthcare during the second quarter worth approximately $37,000. Finally, Fortitude Family Office LLC increased its position in Tenet Healthcare by 52.1% during the third quarter. Fortitude Family Office LLC now owns 222 shares of the company’s stock worth $57,000 after purchasing an additional 76 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.

Recommended Stories

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.